Results 161 to 170 of about 854 (190)

Validating the DPC Immulite chemiluminescent immunoassay serum prolactin for use with the PEG precipitation test for macroprolactinemia screening

, 2005
Claudio Eduardo Farias Nunes Pereira
openalex   +1 more source

Stress-Induced Hyperprolactinemia Mimicking Pituitary Pathology: A Diagnostic Challenge. [PDF]

Cureus
Vats K, Kurian John R, Ann Korah S.
europepmc   +1 more source

Clinical, hormonal and radiological features, and treatment outcomes of prolactinomas in a pediatric population. [PDF]

North Clin Istanb
Emeksiz HC.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Macroprolactinemia in hyperprolactinemic infertile women

Endocrine, 2013
Hyperprolactinemia occurs in 15-20 % of women with menstrual disturbances and 30-40 % of infertile women and it can adversely affect the fertility. High molecular weight prolactin (macroprolactin) has long been known in hyperprolactinemic fertile women.
Krithika, Thirunavakkarasu, Pinaki, Dutta, Subbiah, Sridhar, Lakhbir, Dhaliwal, G R V, Prashad, Shalini, Gainder, Naresh, Sachdeva, Anil, Bhansali   +7 more
openaire   +2 more sources

MACROPROLACTINEMIA: CLINICAL SIGNIFICANCE AND CHARACTERIZATION OF THE CONDITION

Acta Clinica Belgica, 2005
The purpose of this study was to characterize the clinical picture of macroprolactinemic patients and to further assess whether macroprolactinemia was part of an auto-immune syndrome. Eighty-two hyperprolactinemic (serum PRL > 1000 mU/l) patients were investigated and the PEG precipitation test identified 14 patients with macroprolactinemia (bb PRL ...
Theunissen, C., De Schepper, J., Schiettecatte, J., Verdood, P., Hooghe-Peeters, E. L., Velkeniers, B.   +5 more
openaire   +3 more sources

Hyperthyroidism, Hyperprolactinemia, and Macroprolactinemia

Annals of Internal Medicine, 1990
Excerpt To the Editor:We read with interest the excellent review on thyrotropin-secreting pituitary adenomas by Gesundheit and colleagues (1).
Jacobo Wortsman, William B. Malarkey
openaire   +1 more source

Prevalence and reproductive manifestations of macroprolactinemia

Endocrine, 2018
Macroprolactinemia is characterized by predominance of macroprolactin molecules in circulation and generally has extra-pituitary origin. Macroprolactin is viewed as biologically inactive, therefore asymptomatic, and thus may not require any treatment or prolonged follow-up.
Amanpreet Kaur, Kalsi, Ashutosh, Halder, Manish, Jain, P K, Chaturvedi, J B, Sharma   +4 more
openaire   +2 more sources